{"abstract": "The effort to do a deal for Allergan, with a market value of $42 billion, puts together one of the most prominent hedge fund managers with Valeant, a drug maker known for its serial acquisitions.", "web_url": "https://dealbook.nytimes.com/2014/04/21/william-ackman-and-drug-maker-prepare-bid-for-botox-maker/", "snippet": "The effort to do a deal for Allergan, with a market value of $42 billion, puts together one of the most prominent hedge fund managers with Valeant, a drug maker known for its serial acquisitions.", "lead_paragraph": "Updated, 9:12 p.m. | Activist investors are exerting ever more influence on corporate America, pressing companies to cut costs, replace executives and strike deals. On Monday, William A. Ackman, among the brashest men on Wall Street, made perhaps the boldest move yet for an activist.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/22/business/Botox2/Botox2-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/04/22/business/Botox2/Botox2-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/22/business/Botox2/Botox2-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/22/business/Botox2/Botox2-superJumbo.jpg", "height": 1366, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/22/business/Botox2/Botox2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/04/22/business/Botox2/Botox2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/22/business/Botox2/Botox2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Ackman and Valeant Prepare Unusual Hostile Bid for Maker of Botox", "kicker": "DealBook", "content_kicker": null, "print_headline": "Unusual Hostile Bid for Maker of Botox", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Hedge Funds", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "persons", "value": "Ackman, William A", "rank": 4, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 7, "major": "N"}], "pub_date": "2014-04-21T21:19:40+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles, Michael J. de la Merced and Alexandra Stevenson", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}, {"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 2}, {"firstname": "Alexandra", "middlename": null, "lastname": "Stevenson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 3}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d2587924-2f85-59b8-8895-574064c91781", "word_count": 1326, "uri": "nyt://article/d2587924-2f85-59b8-8895-574064c91781"}